The Efficacy and Acceptability of a Remotely Delivered Transdiagnostic Cognitive Behavioural Therapy (CBT) Treatment for Perinatal Anxiety: A Case Series

Not Applicable

Completed

• Conditions: Perinatal anxiety; Mental Health - Anxiety

• Registration Number: ACTRN12621000843853
• Lead Sponsor: niversity of New England

Brief Summary

Three postpartum women engaged in the remotely delivered treatment. All three women reported that they found the treatment helpful and acceptable. The three women no longer met diagnostic diagnostic criteria for their primary anxiety disorder post treatment, which was maintained at three-month follow-up. The intervention was found to be an acceptable form of therapy, however parenting confidence and maternal feelings of bonding did not significantly improve from pre-treatment to post-treatment.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-01
• Study Completion: 2022-03-04
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 3

Inclusion Criteria

(a) Currently in the first 10 months postpartum (participants must be within 10 months postpartum to ensure treatment is delivered during the perinatal period);
(b) Proficient in English;
(c) 18 years of age or above;
(d) Have regular access to the internet;
(e) Meet DSM-5 diagnostic criteria for an anxiety or related disorder as primary (as determined by the DIAMOND);
(f) No history of psychotic illness or bipolar disorder;
(g) A score of at least 8 on the Overall Anxiety Severity and Impairment Scale (OASIS)
(h) If using medication, the medication is a stable dose
(i) Does not report suicidal ideation and intent (as identified through risk related questions during interview)
(j) Does not report recent (i.e., past 3 months) suicide attempts or deliberate self-harm
(k) Does not report past or present psychosis (assessed using the DIAMOND)
(l) A score of below 3 on item 10 of the Edinburgh Postnatal Depression Scale (EPDS)

Exclusion Criteria

(a)Currently not in the first 10 months postpartum
(b)Not proficient in English
(c)Under 18years of age
(d)Do not have regular access to the internet
(e)Does not endorse one of the anxiety and related disorders on the DIAMOND screener
(f)History of a psychotic illness or bipolar disorder
(g)Does not have a score of at least 8 on the Overall Anxiety Severity and Impairment Scale (OASIS)
(h)Not on a stable dose of pharmacological medication
(i)Report suicidal ideation and intent (as identified through risk related questions during interview).
(j)Recent (i.e., past 3 months) suicide attempts or deliberate self-harm
(k)Report past or present psychosis (assessed using the DIAMOND)
(l)Are at high risk of suicide as determined by a score of 3 on item 10 of the Edinburgh Postnatal Depression Scale (EPDS).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) - diagnostic clarification [Pre-treatment, post-treatment, 3 month follow up];The Overall Anxiety Severity and Impairment Scale (OASIS) - mean OASIS score[Pre-treatment, weekly, post-treatment, 3 month follow up];The Edinburgh Postnatal Depression Scale (EPDS) - mean EPDS score [Pre-treatment, weekly, post-treatment, 3 month follow up]

Secondary Outcome Measures

Name	Time	Method
The Maternal Postnatal Attachment Scale (MPAS) - mean score on MPAS[Administered pre-treatment, post-treatment, 3 month follow up];The Karitane Parenting Confidence Scale (KPCS) - mean KPCS score[Pre-treatment, post-treatment, 3 month follow up];The Kessler 10-Item Psychological Distress Scale (K-10) - mean K-10 score[Pre-treatment, post-treatment, 3 month follow up]